Eltek ex-director trades 852 shares, exercises options

The reported transactions pair a 100-option exercise with the acquisition of 589 ordinary shares and sale of 852 ordinary shares.

Available on EDGAR 09/23/2026 - 08:46 AM EDT Accepted by SEC EDGAR 09/23/2026 - 08:46 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ELTEK LTD (ELTK) former director Dovev Gad reported an exercise of 100 employee stock options on September 22, 2026, at an exercise price of $5.89 per share, covering 100 ordinary shares. The reported option position following the transaction was 29,400 options. On the same date, he also reported acquiring 589 ordinary shares at $5.89 per share and selling 852 ordinary shares at $8.52 per share. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 3 txns

Insider Dovev Gad

Role Director

Sold 852 shs ($7K)

Approx. gross sale proceeds $7K

Approx. exercise cost $589.00

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option F1	100	$0.00	$0.00
Exercise	Ordinary share	589	$5.89	$3K
Sale	Ordinary share	852	$8.52	$7K

Holdings After Transaction: Employee Stock Option — 29,400 options (Direct); Ordinary share — 0 shares (Direct)

Footnotes (1)

1. F1. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on September 6, 2021

Key Figures

Employee stock options exercised: 100 options Option exercise price: $5.89 per share Options following transaction: 29,400 options +2 more

5 metrics

Employee stock options exercised 100 options September 22, 2026; covering 100 ordinary shares

Option exercise price $5.89 per share 100 employee stock options exercised on September 22, 2026

Options following transaction 29,400 options Reported following the September 22, 2026 transaction

Ordinary shares acquired 589 shares $5.89 per share on September 22, 2026

Ordinary shares sold 852 shares $8.52 per share on September 22, 2026

Key Terms

option agreement, exercisable, grant date

3 terms

option agreement financial

"The option agreement provides that the option"

An option agreement is a contract that gives one party the right, but not the obligation, to buy or sell a specific asset (like company shares or property) at a pre-agreed price within a set time period. Think of it like a reservation or ticket that holds a purchase at today’s terms for later — it matters to investors because it can create potential future value or liability, change ownership stakes, and affect share dilution and company control.

exercisable financial

"option will become exercisable over a four-year period"

grant date financial

"first anniversary of the grant date"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ELTK transactions did former director Dovev Gad report?

On September 22, 2026, Dovev Gad, identified as a former director, reported exercising options covering 100 ordinary shares at a $5.89 exercise price. He also reported acquiring 589 ordinary shares at $5.89 per share and selling 852 ordinary shares at $8.52 per share.

How many ELTEK options were exercised, and what option position was reported afterward?

The reported exercise covered 100 employee stock options at an exercise price of $5.89 per share. The reported option position following the transaction was 29,400 options.

How many ELTK shares were sold and at what price?

Dovev Gad reported selling 852 ordinary shares at $8.52 per share on September 22, 2026.

How many ELTK shares were acquired and at what price?

Dovev Gad reported acquiring 589 ordinary shares at $5.89 per share on September 22, 2026.

Does the ELTK transaction report indicate a Rule 10b5-1 plan?

No Rule 10b5-1 plan is reported.

What vesting schedule does the ELTEK option agreement describe?

The option agreement says 25% of the options become exercisable on the first anniversary of the grant date, followed by an additional 6.25% at the end of each subsequent quarter over a four-year period. The option was granted on September 6, 2021.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dovev Gad

(Last) (First) (Middle)

MOTA GUR 12/36

(Street)

GIVAT SHMUEL 5442212

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
ELTEK LTD [ ELTK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Reporting Person: Former Dir.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary share	09/22/2026		M		589	A	$5.89	100	D
Ordinary share	09/22/2026		S		852	D	$8.52	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option	$5.89	09/22/2026		M			100	(1)	09/06/2032	Ordinary share	100	$0	29,400	D

Explanation of Responses:

1. The option agreement provides that the option will become exercisable over a four-year period. Twenty-five percent (25%) of the options will become exercisable on the first anniversary of the grant date, and an additional 6.25% will become exercisable at the end of each subsequent quarter thereafter. The option was granted on September 6, 2021

	/s/ Gad Dovev	09/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)